Pathology
 |
|
7 may 2021 13:07:57 |
| Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh (BMC Infectious Diseases) |
|
Tweet Hyperinflammation in severe COVID-19 infection increases the risk of respiratory failure and one of the cogent reasons of mortality associated with COVID-19. Baricitinib, a janus kinases inhibitor, can potenti... |
| 214 viewsCategory: Immunology, Pathology |
 The effect of sociodemographic factors on COVID-19 incidence of 342 cities in China: a geographically weighted regression model analysis (BMC Infectious Diseases)Epidemiological characteristics of the COVID-19 spring outbreak in Quebec, Canada: a population-based study (BMC Infectious Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
